{"id":"https://openalex.org/W4411908084","doi":"https://doi.org/10.1158/1078-0432.29444395","title":"Supplementary Figure S3 from Practical Considerations for Using the TITE-BOIN Design to Handle Late-Onset Toxicity or Fast Accrual in Phase I Trials","display_name":"Supplementary Figure S3 from Practical Considerations for Using the TITE-BOIN Design to Handle Late-Onset Toxicity or Fast Accrual in Phase I Trials","alternate_titles":[],"publication_year":2025,"publication_date":"2025-07-01","ids":{"openalex":"https://openalex.org/W4411908084","doi":"https://doi.org/10.1158/1078-0432.29444395"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.29444395","doi":"https://doi.org/10.1158/1078-0432.29444395","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.29444395","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"parent_works":[],"lineage":["https://openalex.org/W4411908084"],"child_works_count":0,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.29444395","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080929197","display_name":"Kai Chen","orcid":"https://orcid.org/0000-0001-6773-4760","observed_orcids":["https://orcid.org/0000-0001-6773-4760"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kai Chen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6773-4760","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084877136","display_name":"Ting-Yu Chen","orcid":"https://orcid.org/0000-0002-8525-0759","observed_orcids":["https://orcid.org/0000-0002-8525-0759"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ting-Yu Chen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8525-0759","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021900997","display_name":"Yiming Zhang","orcid":"https://orcid.org/0000-0002-1364-3051","observed_orcids":["https://orcid.org/0000-0002-1364-3051"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yiming Zhang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1364-3051","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052092144","display_name":"Ruitao Lin","orcid":"https://orcid.org/0000-0003-2244-131X","observed_orcids":["https://orcid.org/0000-0003-2244-131X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ruitao Lin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2244-131X","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5019360674","display_name":"Ying Yuan","orcid":"https://orcid.org/0000-0003-3163-480X","observed_orcids":["https://orcid.org/0000-0003-3163-480X","https://orcid.org/0009-0003-4406-2596"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ying Yuan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3163-480X","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11798","display_name":"Optimal Experimental Design Methods","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1803","display_name":"Management Science and Operations Research"},"field":{"id":"https://openalex.org/fields/18","display_name":"Decision Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/late-toxicity","display_name":"late toxicity","score":0.9589999914169312},{"id":"https://openalex.org/keywords/accrual-rate","display_name":"accrual rate","score":0.9110000133514404},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.6169999837875366},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.31200000643730164}],"concepts":[{"id":"https://openalex.org/C4577558","wikidata":"https://www.wikidata.org/wiki/Q384475","display_name":"Accrual","level":3,"score":0.7512616515159607},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.47583436965942383},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.455425888299942},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.36550313234329224},{"id":"https://openalex.org/C200601418","wikidata":"https://www.wikidata.org/wiki/Q2193887","display_name":"Reliability engineering","level":1,"score":0.3555047810077667},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2859680652618408},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.22547072172164917},{"id":"https://openalex.org/C121955636","wikidata":"https://www.wikidata.org/wiki/Q4116214","display_name":"Accounting","level":1,"score":0.22516363859176636},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.18704679608345032},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1486101746559143},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.13980382680892944},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C2781426361","wikidata":"https://www.wikidata.org/wiki/Q5326940","display_name":"Earnings","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.29444395","doi":"https://doi.org/10.1158/1078-0432.29444395","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.29444395","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.29444395","doi":"https://doi.org/10.1158/1078-0432.29444395","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.29444395","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.5683000087738037}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4411908069","https://openalex.org/W4410119637","https://openalex.org/W4361947430","https://openalex.org/W2804829033","https://openalex.org/W3046977721","https://openalex.org/W4361959961","https://openalex.org/W4399525948","https://openalex.org/W4402147544","https://openalex.org/W2470227280","https://openalex.org/W3174316206"],"abstract_inverted_index":{"Comparative":[0],"performances":[1],"of":[2,12,21],"TITE-BOIN":[3],"designs":[4],"relative":[5],"to":[6,18],"BOIN":[7],"under":[8],"different":[9],"A/I":[10],"ratios":[11],"1,":[13,22],"6":[14,23],"and":[15,24],"10,":[16],"corresponding":[17],"accrual":[19],"rates":[20],"10":[25],"patients":[26],"per":[27],"month.":[28]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4411908084","counts_by_year":[],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2025-10-10T00:00:00"}
